Dose Finding Study In Subjects With Crow's Feet

Completed · Phase 2

Conditions studied: Lateral Canthal Lines, Crow's Feet

In brief

The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.

Key facts

Study ID

NCT01951742

Run by

Anterios Inc.

People needed

145

Starts

2013-09-01

Expected to finish

2014-01-01

Last updated by the study team

2014-05-29

Who can join

Age: 30 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 30 - 60 years of age
• mild to moderate Crow's Feet wrinkles at rest
• moderate to severe Crow's Feet wrinkles on contraction
• willingness to refrain from any product affecting skin remodeling
• female subjects must be not pregnant and non-lactating

You may not qualify if…

• history of peri-ocular surgery, brow lift or related procedures
• procedures affecting the lateral canthal region in the prior 12 months
• application of topical prescription medication to the treatment area
• female subjects who are pregnant or are nursing a child

Where it is running

• Study site — Miami, Florida, United States
• Study site — Pinellas Park, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Metairie, Louisiana, United States
• Study site — New Orleans, Louisiana, United States
• Study site — Rochester, New York, United States
• Study site — High Point, North Carolina, United States
• Study site — Knoxville, Tennessee, United States
• Study site — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.